| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/13651500601117215 |
| P698 | PubMed publication ID | 24940728 |
| P2093 | author name string | Ender Taner | |
| Ersin Hatice Karslioğlu | |||
| Behçet Coşar | |||
| Hande Karakiliç | |||
| P2860 | cites work | Acute psychotic symptoms induced by topiramate | Q28371093 |
| Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables | Q31402130 | ||
| A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group | Q33328672 | ||
| Topiramate antagonizes MK-801 in an animal model of schizophrenia | Q33845809 | ||
| Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression | Q33961518 | ||
| A revised excitotoxic hypothesis of schizophrenia: therapeutic implications | Q34210187 | ||
| Open-label adjunctive topiramate in the treatment of bipolar disorders. | Q34509360 | ||
| The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder | Q34576250 | ||
| Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate | Q34976043 | ||
| Depression in epilepsy: a common but often unrecognized comorbid malady | Q35074447 | ||
| Evidence of glutamatergic deficiency in schizophrenia | Q41134039 | ||
| Drug treatment of epilepsy in the 1990s. Achievements and new developments. | Q41188326 | ||
| Schizophrenia-like psychosis and epilepsy: the status of the association. | Q41720716 | ||
| Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder | Q43734626 | ||
| Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication. | Q43756161 | ||
| Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study | Q43841267 | ||
| Is topiramate effective for weight loss in neuroleptic-induced obesity? 2 case reports | Q43903850 | ||
| Topiramate for refractory schizophrenia | Q43941610 | ||
| Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia | Q44536108 | ||
| The importance of being seizure free: topiramate and psychopathology in epilepsy | Q44537811 | ||
| A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events | Q44607327 | ||
| Topiramate-induced psychosis | Q46628170 | ||
| Use of topiramate, a new anti-epileptic as a mood stabilizer | Q48777380 | ||
| A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. | Q52024331 | ||
| Acute psychotic disorders induced by topiramate: report of two cases | Q57086623 | ||
| P433 | issue | 4 | |
| P921 | main subject | Behçet's disease | Q911427 |
| psychosis | Q170082 | ||
| P304 | page(s) | 285-290 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | International Journal of Psychiatry in Clinical Practice | Q15746484 |
| P1476 | title | Topiramate-induced psychotic exacerbation: case report and review of literature | |
| P478 | volume | 11 |
Search more.